Skip to main content
Caplight Logo









EntroGen, Inc.

EntroGen, Inc.

Private
Woodland Hills, CaliforniaHealthcare & Life Scienceshttps://entrogen.com/web4/

Momentum

Top 25%

of companies Caplight tracks

Company Overview

EntroGen, Inc. is a biotechnology company that develops and offers end-to-end solutions in molecular diagnostics for oncology and hematology by providing hardware, reagents, and software.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

molecular diagnosticsoncology diagnosticsdiagnostic assaysmutation detectionreal-time PCRqPCRnext-generation sequencingNGScompanion diagnosticshematology diagnosticsliquid biopsyvariant analysis softwarecell-free DNAcfDNAnucleic acid isolationlab automationISO 13485

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EntroGen, Inc. Comparables

Compare EntroGen, Inc. with similar companies based on industry and business-model similarity.

EntroGen, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pillar Biosciences
84%
Amoy Diagnostics Co., Ltd.
79%
Luye Pharma Group
76%

EntroGen, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 46% MoM.

  • Jul 27, 2026

    Monthly visitors increased 34% MoM, reaching 2.2K.

EntroGen, Inc. Filings

Explore SEC and related filing metadata, where available.

EntroGen, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EntroGen, Inc.'s valuation, stock price, and market status.

Is EntroGen, Inc. a public or private company?

EntroGen, Inc. is a private company.

What is the current stock price of EntroGen, Inc.?

EntroGen, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is EntroGen, Inc. worth (valuation)?

Valuation information for EntroGen, Inc. is not publicly available.

Can I buy EntroGen, Inc. stock?

EntroGen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EntroGen, Inc.'s last funding round?

Funding round information for EntroGen, Inc. is not publicly available.

Who are the main investors in EntroGen, Inc.?

Investor information for EntroGen, Inc. is not publicly disclosed.

Will EntroGen, Inc. IPO soon?

No public IPO plans have been announced for EntroGen, Inc..

How can I track EntroGen, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EntroGen, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWoodland Hills, California
Employee Range22
Year Founded2007
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?